Faith Davies, MD

    Faith Davies, MD

    Professor of Medicine, Myeloma Institute for Research and Therapy, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences
    • Is MRD Testing Worthwhile in Myeloma? Friday, June 16th, 2017

      With the clinically effective treatment regimens now available for myeloma, more patients can achieve deep and sustained responses. The ability to measure minimal residual disease (MRD) during and after treatment has the potential to help guide treatment decisions and predict patients’ likelihood of relapse, but is MRD monitoring ready to be used in routine clinical [...]

    SHARE